These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 26021840)
1. Association Study of the TREM2 Gene and Identification of a Novel Variant in Exon 2 in Iranian Patients with Late-Onset Alzheimer's Disease. Mehrjoo Z; Najmabadi A; Abedini SS; Mohseni M; Kamali K; Najmabadi H; Khorram Khorshid HR Med Princ Pract; 2015; 24(4):351-4. PubMed ID: 26021840 [TBL] [Abstract][Full Text] [Related]
2. TREM2 variants and risk of Alzheimer's disease: a meta-analysis. Lu Y; Liu W; Wang X Neurol Sci; 2015 Oct; 36(10):1881-8. PubMed ID: 26037549 [TBL] [Abstract][Full Text] [Related]
3. TREM2 R47H variant as a risk factor for early-onset Alzheimer's disease. Pottier C; Wallon D; Rousseau S; Rovelet-Lecrux A; Richard AC; Rollin-Sillaire A; Frebourg T; Campion D; Hannequin D J Alzheimers Dis; 2013; 35(1):45-9. PubMed ID: 23380991 [TBL] [Abstract][Full Text] [Related]
4. The p.R47H Variant of TREM2 Gene is Associated With Late-onset Alzheimer Disease in Colombian Population. Arboleda-Bustos CE; Ortega-Rojas J; Mahecha MF; Arboleda G; Vásquez R; Pardo R; Arboleda H Alzheimer Dis Assoc Disord; 2018; 32(4):305-308. PubMed ID: 30222607 [TBL] [Abstract][Full Text] [Related]
5. Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia. Ruiz A; Dols-Icardo O; Bullido MJ; Pastor P; Rodríguez-Rodríguez E; López de Munain A; de Pancorbo MM; Pérez-Tur J; Alvarez V; Antonell A; López-Arrieta J; Hernández I; Tárraga L; Boada M; Lleó A; Blesa R; Frank-García A; Sastre I; Razquin C; Ortega-Cubero S; Lorenzo E; Sánchez-Juan P; Combarros O; Moreno F; Gorostidi A; Elcoroaristizabal X; Baquero M; Coto E; Sánchez-Valle R; Clarimón J; Neurobiol Aging; 2014 Feb; 35(2):444.e1-4. PubMed ID: 24041969 [TBL] [Abstract][Full Text] [Related]
6. R47H Variant of TREM2 Associated With Alzheimer Disease in a Large Late-Onset Family: Clinical, Genetic, and Neuropathological Study. Korvatska O; Leverenz JB; Jayadev S; McMillan P; Kurtz I; Guo X; Rumbaugh M; Matsushita M; Girirajan S; Dorschner MO; Kiianitsa K; Yu CE; Brkanac Z; Garden GA; Raskind WH; Bird TD JAMA Neurol; 2015 Aug; 72(8):920-7. PubMed ID: 26076170 [TBL] [Abstract][Full Text] [Related]
7. TREM2 variants in Alzheimer's disease. Guerreiro R; Wojtas A; Bras J; Carrasquillo M; Rogaeva E; Majounie E; Cruchaga C; Sassi C; Kauwe JS; Younkin S; Hazrati L; Collinge J; Pocock J; Lashley T; Williams J; Lambert JC; Amouyel P; Goate A; Rademakers R; Morgan K; Powell J; St George-Hyslop P; Singleton A; Hardy J; N Engl J Med; 2013 Jan; 368(2):117-27. PubMed ID: 23150934 [TBL] [Abstract][Full Text] [Related]
8. R47H TREM2 variant increases risk of typical early-onset Alzheimer's disease but not of prion or frontotemporal dementia. Slattery CF; Beck JA; Harper L; Adamson G; Abdi Z; Uphill J; Campbell T; Druyeh R; Mahoney CJ; Rohrer JD; Kenny J; Lowe J; Leung KK; Barnes J; Clegg SL; Blair M; Nicholas JM; Guerreiro RJ; Rowe JB; Ponto C; Zerr I; Kretzschmar H; Gambetti P; Crutch SJ; Warren JD; Rossor MN; Fox NC; Collinge J; Schott JM; Mead S Alzheimers Dement; 2014 Nov; 10(6):602-608.e4. PubMed ID: 25160042 [TBL] [Abstract][Full Text] [Related]
9. Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia. Cuyvers E; Bettens K; Philtjens S; Van Langenhove T; Gijselinck I; van der Zee J; Engelborghs S; Vandenbulcke M; Van Dongen J; Geerts N; Maes G; Mattheijssens M; Peeters K; Cras P; Vandenberghe R; De Deyn PP; Van Broeckhoven C; Cruts M; Sleegers K; Neurobiol Aging; 2014 Mar; 35(3):726.e11-9. PubMed ID: 24119542 [TBL] [Abstract][Full Text] [Related]
10. Association study of TREM2 polymorphism rs75932628 with late-onset Alzheimer's disease in Chinese Han population. Ma J; Zhou Y; Xu J; Liu X; Wang Y; Deng Y; Wang G; Xu W; Ren R; Liu X; Zhang Y; Wang C; Tang H; Chen S Neurol Res; 2014 Oct; 36(10):894-6. PubMed ID: 24725293 [TBL] [Abstract][Full Text] [Related]
11. TREM2 is associated with the risk of Alzheimer's disease in Spanish population. Benitez BA; Cooper B; Pastor P; Jin SC; Lorenzo E; Cervantes S; Cruchaga C Neurobiol Aging; 2013 Jun; 34(6):1711.e15-7. PubMed ID: 23391427 [TBL] [Abstract][Full Text] [Related]
12. Alternative Splicing Regulation of Low-Frequency Genetic Variants in Exon 2 of Han S; Na Y; Koh I; Nho K; Lee Y Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576031 [No Abstract] [Full Text] [Related]
13. Variant of TREM2 associated with the risk of Alzheimer's disease. Jonsson T; Stefansson H; Steinberg S; Jonsdottir I; Jonsson PV; Snaedal J; Bjornsson S; Huttenlocher J; Levey AI; Lah JJ; Rujescu D; Hampel H; Giegling I; Andreassen OA; Engedal K; Ulstein I; Djurovic S; Ibrahim-Verbaas C; Hofman A; Ikram MA; van Duijn CM; Thorsteinsdottir U; Kong A; Stefansson K N Engl J Med; 2013 Jan; 368(2):107-16. PubMed ID: 23150908 [TBL] [Abstract][Full Text] [Related]
14. Heterozygous TREM2 mutations in frontotemporal dementia. Borroni B; Ferrari F; Galimberti D; Nacmias B; Barone C; Bagnoli S; Fenoglio C; Piaceri I; Archetti S; Bonvicini C; Gennarelli M; Turla M; Scarpini E; Sorbi S; Padovani A Neurobiol Aging; 2014 Apr; 35(4):934.e7-10. PubMed ID: 24139279 [TBL] [Abstract][Full Text] [Related]
16. Assessment of TREM2 rs75932628 association with Alzheimer's disease in a population-based sample: the Cache County Study. Gonzalez Murcia JD; Schmutz C; Munger C; Perkes A; Gustin A; Peterson M; Ebbert MT; Norton MC; Tschanz JT; Munger RG; Corcoran CD; Kauwe JS Neurobiol Aging; 2013 Dec; 34(12):2889.e11-3. PubMed ID: 23855982 [TBL] [Abstract][Full Text] [Related]
17. A rare coding variant in TREM2 increases risk for Alzheimer's disease in Han Chinese. Jiang T; Tan L; Chen Q; Tan MS; Zhou JS; Zhu XC; Lu H; Wang HF; Zhang YD; Yu JT Neurobiol Aging; 2016 Jun; 42():217.e1-3. PubMed ID: 27067662 [TBL] [Abstract][Full Text] [Related]
18. The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease. Lill CM; Rengmark A; Pihlstrøm L; Fogh I; Shatunov A; Sleiman PM; Wang LS; Liu T; Lassen CF; Meissner E; Alexopoulos P; Calvo A; Chio A; Dizdar N; Faltraco F; Forsgren L; Kirchheiner J; Kurz A; Larsen JP; Liebsch M; Linder J; Morrison KE; Nissbrandt H; Otto M; Pahnke J; Partch A; Restagno G; Rujescu D; Schnack C; Shaw CE; Shaw PJ; Tumani H; Tysnes OB; Valladares O; Silani V; van den Berg LH; van Rheenen W; Veldink JH; Lindenberger U; Steinhagen-Thiessen E; ; Teipel S; Perneczky R; Hakonarson H; Hampel H; von Arnim CAF; Olsen JH; Van Deerlin VM; Al-Chalabi A; Toft M; Ritz B; Bertram L Alzheimers Dement; 2015 Dec; 11(12):1407-1416. PubMed ID: 25936935 [TBL] [Abstract][Full Text] [Related]
19. Lack of association between triggering receptor expressed on myeloid cells 2 polymorphism rs75932628 and late-onset Alzheimer's disease in a Chinese Han population. Wang P; Guo Q; Zhou Y; Chen K; Xu Y; Ding D; Hong Z; Zhao Q Psychiatr Genet; 2018 Feb; 28(1):16-18. PubMed ID: 29256968 [TBL] [Abstract][Full Text] [Related]
20. Genetic Analysis of TREM2 Variants in Tunisian Patients with Alzheimer's Disease. Landoulsi Z; Ben Djebara M; Kacem I; Sidhom Y; Kefi R; Abdelhak S; Gargouri-Berrechid A; Gouider R Med Princ Pract; 2018; 27(4):317-322. PubMed ID: 29723869 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]